Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -10.28%43.88M | 8.95%138.05M | -28.74%48.91M | -7.60%126.71M | -17.23%68.63M | 17.56%137.14M | 69.10%82.92M | -26.51%116.66M | -39.27%49.04M | 16.85%158.73M |
| Operating income | -10.28%43.88M | 8.95%138.05M | -28.74%48.91M | -7.60%126.71M | -17.23%68.63M | 17.56%137.14M | 69.10%82.92M | -26.51%116.66M | -39.27%49.04M | 16.85%158.73M |
| Cost of sales | 43.35%-24.89M | -2.24%-112.57M | 30.06%-43.94M | 13.10%-110.1M | 21.97%-62.83M | -1.32%-126.7M | -70.60%-80.52M | 31.67%-125.05M | 44.38%-47.2M | -130.44%-183.01M |
| Operating expenses | 43.35%-24.89M | -2.24%-112.57M | 30.06%-43.94M | 13.10%-110.1M | 21.97%-62.83M | -1.32%-126.7M | -70.60%-80.52M | 31.67%-125.05M | 44.38%-47.2M | -130.44%-183.01M |
| Gross profit | 282.32%18.99M | 53.43%25.48M | -14.42%4.97M | 59.16%16.61M | 142.14%5.8M | 224.31%10.44M | 30.48%2.4M | 65.43%-8.39M | 144.68%1.84M | -143.03%-24.28M |
| Selling expenses | ---- | 74.74%-3.51M | ---- | -21.83%-13.89M | 21.29%-6.57M | 17.61%-11.4M | -16.90%-8.34M | 24.64%-13.84M | 4.41%-7.14M | -34.80%-18.36M |
| Administrative expenses | -5.09%-13.04M | -7.10%-59.6M | 48.85%-12.41M | 17.78%-55.64M | 46.38%-24.27M | 18.30%-67.68M | -1.12%-45.25M | 20.16%-82.83M | 11.81%-44.75M | -27.66%-103.74M |
| Revaluation surplus | ---- | -8.76%-266.11M | ---- | -24.56%-244.68M | -2,821.38%-37.57M | -151.30%-196.43M | 98.22%-1.29M | -4,301.18%-78.17M | -350.38%-72.43M | 93.98%-1.78M |
| -Changes in the fair value of investment property | ---- | -8.76%-266.11M | ---- | -26.20%-244.68M | -3,512.40%-37.57M | -179.52%-193.89M | 98.40%-1.04M | -1,596.82%-69.37M | -303.01%-64.81M | 85.56%-4.09M |
| -Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | ---- | 71.12%-2.54M | 96.77%-246K | -480.58%-8.8M | ---7.62M | 296.26%2.31M |
| Impairment and provision | ---- | 25.96%-80.78M | 104.58%870K | -124.82%-109.1M | ---18.99M | -749.89%-48.53M | ---- | 97.17%-5.71M | ---- | -1,168.88%-202.04M |
| -Impairment of property, machinery and equipment | ---- | 23.03%-71.36M | ---- | -97.28%-92.71M | ---15.3M | -723.01%-46.99M | ---- | 96.19%-5.71M | ---- | -1,221.23%-149.92M |
| -Other impairment is provision | ---- | 42.53%-9.42M | 123.58%870K | -967.82%-16.39M | ---3.69M | ---1.54M | ---- | ---- | ---- | -1,039.07%-52.12M |
| Special items of operating profit | -44.31%876K | 200.66%2.13M | -18.50%1.57M | -1,147.03%-2.12M | 235.63%1.93M | 126.20%202K | -140.44%-1.42M | 92.73%-771K | 146.77%3.52M | -1,205.21%-10.6M |
| Operating profit | 236.39%6.82M | 6.47%-382.37M | 93.72%-5M | -30.45%-408.82M | -47.77%-79.65M | -65.20%-313.4M | 54.69%-53.91M | 47.42%-189.71M | -54.54%-118.96M | -352.27%-360.8M |
| Financing income | -33.33%2K | -66.67%10K | -84.21%3K | -36.17%30K | -40.63%19K | -25.40%47K | 39.13%32K | -72.61%63K | -84.67%23K | 475.00%230K |
| Financing cost | -31.11%-16.55M | -51.97%-208.54M | 83.99%-12.63M | 18.28%-137.22M | 11.41%-78.84M | 9.53%-167.92M | 8.11%-89M | -20.21%-185.6M | -53.89%-96.85M | -57.06%-154.4M |
| Earning before tax | 44.79%-9.73M | -8.22%-590.9M | 88.88%-17.63M | -13.45%-546.02M | -10.92%-158.48M | -28.26%-481.27M | 33.79%-142.87M | 27.13%-375.24M | -54.40%-215.78M | -189.24%-514.97M |
| Tax | -7.57%-4.62M | 83.19%-926K | -265.93%-4.3M | -168.16%-5.51M | 63.52%-1.17M | -461.20%-2.05M | -120.58%-3.22M | 92.88%-366K | 687.76%15.64M | 79.32%-5.14M |
| After-tax profit from continuing operations | 34.53%-14.35M | -7.31%-591.83M | 86.27%-21.92M | -14.11%-551.52M | -9.28%-159.65M | -28.68%-483.33M | 27.01%-146.09M | 27.78%-375.61M | -45.27%-200.15M | -156.32%-520.11M |
| After-tax profit from non-continuing business | 392.51%464.76M | ---- | ---158.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 349.11%450.41M | -7.31%-591.83M | -13.25%-180.81M | -14.11%-551.52M | -9.28%-159.65M | -28.68%-483.33M | 27.01%-146.09M | 27.78%-375.61M | -45.27%-200.15M | -156.32%-520.11M |
| Minority profit | 89.45%-65K | 25.25%382K | -149.20%-616K | 175.68%305K | 62.39%1.25M | 89.60%-403K | 364.95%771K | -326.34%-3.88M | -124.64%-291K | --1.71M |
| Shareholders should account for profits from continuing business | 32.95%-14.29M | ---- | ---21.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Shareholders should account for profits from non-continuing business | 392.51%464.76M | ---- | ---158.89M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 350.00%450.47M | -7.32%-592.21M | -11.99%-180.19M | -14.27%-551.83M | -9.56%-160.91M | -29.91%-482.92M | 26.52%-146.86M | 28.76%-371.74M | -43.83%-199.86M | -157.16%-521.82M |
| Basic earnings per share | 350.00%0.7 | -8.24%-0.92 | -12.00%-0.28 | -13.33%-0.85 | -10.18%-0.25 | -8.70%-0.75 | 49.80%-0.2269 | 45.24%-0.69 | -38.91%-0.452 | -137.74%-1.26 |
| Diluted earnings per share | 350.00%0.7 | -8.24%-0.92 | -12.00%-0.28 | -13.33%-0.85 | -10.18%-0.25 | -8.70%-0.75 | 49.80%-0.2269 | 45.24%-0.69 | -38.91%-0.452 | -137.74%-1.26 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.